Literature DB >> 1890181

Serological follow-up of patients involved in a localized outbreak of leptospirosis.

R Lupidi1, M Cinco, D Balanzin, E Delprete, P E Varaldo.   

Abstract

Eighteen patients involved in a localized outbreak of leptospirosis were subjected to a serological follow-up study over a 5-year period. Four distinct sets of sera from all patients and a fifth sample obtained from 10 of them were examined by the microscopic agglutination test (MAT) for demonstration of leptospiral antibodies. The test was carried out by using live leptospires from reference strains of 17 Leptospira interrogans serovars known to occur in Italy. In all cases, the highest titers of agglutinins were recorded against one or more of the three Australis group serovars tested (australis, bratislava, and lora). The highest antibody levels were reached soon after the acute phase of infection in some patients but only after some months in others. Titers then tended to recede with varying rapidity, but titers against the Australis group serovars were still detectable in some patients after 5 years. Coagglutinins against serovars of other serogroups were detected, generally at low levels, in the early sets of sera of most patients, but tended to disappear in the late-set sera. Specific immunoglobulin M (IgM) and IgG against the three Australis group serovars were determined in most serum samples from 16 patients by solid-phase enzyme immunoassay (EIA). In general, EIA titers were considerably lower than MAT titers, but there was a certain patient-to-patient variability in both the IgM/IgG ratio and the evolution and persistence of the two immunoglobulin classes. Since all the evidence indicated that the initial outbreak from a single source, the observed patient-to-patient variability in the progress of both MAT and EIA titers appeared to be attributable to factors inherent in the individual patients. Cross agglutination absorption tests, aimed at retrospectively determining to which of the Australis group serovars the outbreak-specific infecting strain belonged, were performed with six serum samples from different patients. Most absorbed sera seemed to originate from an australis or lora infection, but it was not possible to discriminate conclusively between the two serovars.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1890181      PMCID: PMC269874          DOI: 10.1128/jcm.29.4.805-809.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Recent trends in human leptospirosis in Italy.

Authors:  L Ciceroni; A Pinto; B Cacciapuoti
Journal:  Eur J Epidemiol       Date:  1988-03       Impact factor: 8.082

2.  A waterborne outbreak of leptospirosis.

Authors:  B Cacciapuoti; L Ciceroni; C Maffei; F Di Stanislao; P Strusi; L Calegari; R Lupidi; G Scalise; G Cagnoni; G Renga
Journal:  Am J Epidemiol       Date:  1987-09       Impact factor: 4.897

Review 3.  Leptospirosis. II. Serology.

Authors:  L H Turner
Journal:  Trans R Soc Trop Med Hyg       Date:  1968       Impact factor: 2.184

4.  The dynamics of IgM- and IgG-antibodies in leptospiral infection in man.

Authors:  Y G Chernukha; Z S Shishkina; P M Baryshev; I L Kokovin
Journal:  Zentralbl Bakteriol Orig A       Date:  1976-11

5.  Heterogeneity of lipopolysaccharide banding patterns in Leptospira spp.

Authors:  M Cinco; E Banfi; E Panfili
Journal:  J Gen Microbiol       Date:  1986-04

6.  The antibodies involved in the human immune response to leptospiral infection.

Authors:  B Adler; S Faine
Journal:  J Med Microbiol       Date:  1978-11       Impact factor: 2.472

7.  First human isolate of Leptospira interrogans as serovar bratislava in Italy.

Authors:  M Cinco; E Banfi; C Stornello; F Campo; H Korver
Journal:  FEMS Microbiol Immunol       Date:  1989-12

8.  Serosurvey on the presence of leptospiral agglutinins in humans in Northern Italy.

Authors:  D Crevatin; E Banfi; D Crotti; E Ruaro; M Cinco
Journal:  Eur J Epidemiol       Date:  1986-03       Impact factor: 8.082

9.  Detection of specific anti-leptospiral immunoglobulins M and G in human serum by solid-phase enzyme-linked immunosorbent assay.

Authors:  B Adler; A M Murphy; S A Locarnini; S Faine
Journal:  J Clin Microbiol       Date:  1980-05       Impact factor: 5.948

10.  Serodiagnosis of human leptospirosis by enzyme-linked-immunosorrbent-assay (ELISA).

Authors:  W J Terpstra; G S Ligthart; G J Schoone
Journal:  Zentralbl Bakteriol A       Date:  1980-08
View more
  28 in total

1.  Lateral-flow assay for rapid serodiagnosis of human leptospirosis.

Authors:  H L Smits; C K Eapen; S Sugathan; M Kuriakose; M H Gasem; C Yersin; D Sasaki; B Pujianto; M Vestering; T H Abdoel; G C Gussenhoven
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

Review 2.  Leptospirosis.

Authors:  P N Levett
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

3.  Risk factors for clinical leptospirosis from Western Jamaica.

Authors:  John Keenan; Genine Ervin; Maung Aung; Gerald McGwin; Pauline Jolly
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

4.  Limited diagnostic capacities of two commercial assays for the detection of Leptospira immunoglobulin M antibodies in Laos.

Authors:  Stuart D Blacksell; Lee Smythe; Rattanaphone Phetsouvanh; Michael Dohnt; Rudy Hartskeerl; Meegan Symonds; Andrew Slack; Manivanh Vongsouvath; Viengmone Davong; Olay Lattana; Simmaly Phongmany; Valy Keolouangkot; Nicholas J White; Nicholas P J Day; Paul N Newton
Journal:  Clin Vaccine Immunol       Date:  2006-10

5.  Leptospira immunoglobulin-like proteins as a serodiagnostic marker for acute leptospirosis.

Authors:  Julio Croda; João G R Ramos; James Matsunaga; Adriano Queiroz; Akira Homma; Lee W Riley; David A Haake; Mitermayer G Reis; Albert I Ko
Journal:  J Clin Microbiol       Date:  2007-03-14       Impact factor: 5.948

6.  Leptospirosis in a subsistence farming community in Brazil.

Authors:  Hênio G Lacerda; Gloria R Monteiro; Carlos C G Oliveira; Fernando B Suassuna; Jose W Queiroz; James D A Barbosa; Daniella R Martins; Mitemayer G Reis; Albert I Ko; Selma M B Jeronimo
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-07-02       Impact factor: 2.184

7.  Evidence of a major reservoir of non-malarial febrile diseases in malaria-endemic regions of Bangladesh.

Authors:  Paul Swoboda; Hans-Peter Fuehrer; Benedikt Ley; Peter Starzengruber; Kamala Ley-Thriemer; Mariella Jung; Julia Matt; Markus A Fally; Milena K S Mueller; Johannes A B Reismann; Rashidul Haque; Wasif A Khan; Harald Noedl
Journal:  Am J Trop Med Hyg       Date:  2014-01-13       Impact factor: 2.345

8.  Prospective serological study of leptospirosis in southern Spain.

Authors:  C Dastis-Bendala; E de Villar-Conde; I Marin-Leon; L Manzanares-Torne; M J Perez-Lozano; G Cano-Fuentes; J Vargas-Romero; T Pumarola-Suñe
Journal:  Eur J Epidemiol       Date:  1996-06       Impact factor: 8.082

9.  Evaluation of a commercial enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody in diagnosis of human leptospiral infection.

Authors:  W E Winslow; D J Merry; M L Pirc; P L Devine
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

Review 10.  Leptospirosis in humans.

Authors:  David A Haake; Paul N Levett
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.